Your trusted destination for CME, CPD & Medical Education across the Middle East.
The International Conference on Heart & Diabetes (ICHD 2026) brings together researchers, healthcare professionals, academics, and practitioners in cardiovascular and diabetes-related fields. The conference provides a platform for research presentations, scientific discussion, knowledge exchange, networking, and collaboration.
The International Conference on Heart & Diabetes (ICHD 2026) is an international scientific conference organized by the Society for Engineering Research (SFER) and scheduled for 25 November 2026 in Mutrah, Oman. The conference focuses on the closely connected areas of cardiovascular health and diabetes, bringing together researchers, academicians, healthcare professionals, practitioners, research scholars, and other stakeholders for scientific exchange and discussion. Heart disease and diabetes represent interconnected areas of healthcare and research, with metabolic health, cardiovascular risk, prevention, diagnosis, and long-term disease management frequently requiring multidisciplinary approaches. The conference provides a forum for participants from different professional and academic backgrounds to discuss research findings, emerging developments, challenges, and potential approaches related to these fields. A major component of ICHD 2026 is the presentation and exchange of research. Participants can present their findings through oral and poster presentations, allowing researchers and professionals to communicate their work to an international audience. These sessions can facilitate discussion of research methodologies, findings, clinical perspectives, and emerging ideas while providing opportunities for participants to receive feedback from peers. The conference is particularly relevant to cardiologists, diabetologists, endocrinologists, internists, biomedical researchers, healthcare practitioners, academics, public-health professionals, and postgraduate researchers. Participants can explore issues at the intersection of cardiovascular and metabolic health, including areas related to diabetes management, cardiovascular risk, prevention, clinical research, and healthcare practice. In addition to formal research presentations, the conference provides opportunities for professional networking and international collaboration. Participants can interact with researchers and healthcare professionals from different institutions and countries, exchange experiences, identify common research interests, and develop professional connections that may support future academic and research projects. The conference also supports research dissemination through scholarly contributions. SFER's conference framework accommodates original research papers, review papers, surveys, case studies, technical reports, and other research-related works. This provides researchers with opportunities to communicate their findings and contribute to broader academic discussions in cardiovascular and diabetes-related research. Another feature of the conference is recognition of research contributions through Best Paper Awards. Selected research presentations may be recognized for their contribution to the conference, encouraging participants to present original and relevant work. Overall, ICHD 2026 provides an international setting for researchers and healthcare professionals to exchange knowledge on heart disease and diabetes. Through research presentations, scientific discussion, professional networking, and collaboration, the conference aims to connect researchers and practitioners while promoting continued development and dissemination of knowledge in cardiovascular and metabolic health.
Latest research on the prevention, diagnosis, and treatment of CAD.
Emerging therapies and management strategies for acute and chronic heart failure.
Advancements in the detection and treatment of cardiac arrhythmias.
Current trends in the pharmacological and lifestyle management of diabetes.
Strategies for mitigating neuropathy, nephropathy, and retinopathy.
Screening, risks, and management of diabetes during pregnancy.
Assessing and lowering the risk of heart disease in patients with diabetes.
Understanding the cluster of conditions that increase the risk of heart disease, stroke, and diabetes.
Pathophysiology and targeted treatments for heart muscle disorders in diabetic patients.
The role of continuous glucose monitors and smartwatches in patient care.
Utilizing artificial intelligence for early detection of cardiovascular and metabolic conditions.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Student (All Masters/PhDs/Research Scholars/Post Doc.) - Early Bird | Early Bird | Oct 11, 2026 | USD 230 |
| Student (All Masters/PhDs/Research Scholars/Post Doc.) - Regular | Regular | — | USD 270 |
| Student (All Masters/PhDs/Research Scholars/Post Doc.) - Video Conference | Video Conference | — | USD 219 |
| Student (All Bachelors) - Early Bird | Early Bird | Oct 11, 2026 | USD 210 |
| Student (All Bachelors) - Regular | Regular | — | USD 250 |
| Student (All Bachelors) - Video Conference | Video Conference | — | USD 199 |
| Delegates (Academician/Industrial Professional) - Early Bird | Early Bird | Oct 11, 2026 | USD 280 |
| Delegates (Academician/Industrial Professional) - Regular | Regular | — | USD 320 |
| Delegates (Academician/Industrial Professional) - Video Conference | Video Conference | — | USD 269 |
| Listeners - Early Bird | Early Bird | Oct 11, 2026 | USD 150 |
| Listeners - Regular | Regular | — | USD 200 |
| Listeners - Video Conference | Video Conference | — | USD 149 |